Listings

In this section

Events

Innovation Rankings

Buyer's Guides

05/14/2024 08:51:52
  • Home | Anticipation rises for RSV rollout as positive data emerges
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • phasetwo
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Trends & Insight
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • Avenga Company Insight
  • In Depth
  • Anticipation rises for RSV rollout as positive data emerges
  • Continuous monitoring expands aseptic knowledge and data in real time
  • Molecular glues are the latest craze in pharma research, but what are they?
  • Using pharmacovigilance to turn reactive investigation into active discovery
  • Lenmeldy becomes world’s most expensive drug
  • Q&A: BARDA wants to back tech that can combat multiple infections, says director
  • Sponsored Supplements
  • ZETA
  • Nipro
  • Listings
  • Events
  • Innovation Rankings
  • Buyer's Guides
  • Next issue
04/18/2024 00:00:00